Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Arcutis Biotherapeutics Inc. (ARQT) Prices 4M Share Common Offering and Concurrent Private Placement
-
Arcutis Biotherapeutics Announces Pricing of Public Offering and Concurrent Private Placement of Common Stock
-
Arcutis Bio (ARQT) Announces 4M Share Proposed Public Offering and Concurrent $35M Private Placement of Common Stock
-
Arcutis Biotherapeutics Announces Proposed Public Offering and Concurrent Private Placement of Common Stock
-
Arcutis to Present at the Cantor Fitzgerald Global Healthcare Conference 2020
-
Companies with NDRs 7/30
-
Companies with NDRs 7/29
-
Companies with NDRs 7/28
-
UPDATE: Cantor Fitzgerald Starts Arcutis Biotherapeutics Inc. (ARQT) at Overweight
-
Arcutis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Arcutis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Arcutis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Arcutis Biotherapeutics (ARQT) IPO Opens at 36% Higher
